{"id":58616,"date":"2024-02-28T05:19:40","date_gmt":"2024-02-28T05:19:40","guid":{"rendered":"https:\/\/medsname.com\/onlee-10\/"},"modified":"2026-04-30T10:24:11","modified_gmt":"2026-04-30T10:24:11","slug":"onlee-10","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/onlee-10\/","title":{"rendered":"Onlee-10"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Onlee-10?<\/h3>\n<p style=\"margin:0;\"><strong>Onlee-10<\/strong> este <strong>olanzapin\u0103 10 mg<\/strong>, un antipsihotic atipic (de genera\u021bia a doua) prescris pentru schizofrenie, manie acut\u0103 \u00een tulburarea bipolar\u0103 tip I \u0219i terapia de \u00eentre\u021binere bipolar\u0103. Doza uzual\u0103: <strong>5\u201310 mg o dat\u0103 pe zi<\/strong>, de obicei la culcare. Efectele secundare principale sunt sedarea, cre\u0219terea \u00een greutate \u0219i modific\u0103rile metabolice \u2014 monitoriza\u021bi greutatea, glicemia \u0219i lipidele \u00een mod regulat \u00een timpul tratamentului.<\/p>\n<\/div>\n<p><strong>Onlee-10<\/strong> este un <strong>comprimat olanzapine 10 mg<\/strong> \u2014 un antipsihotic atipic (de genera\u021bia a doua) utilizat pentru tratarea <strong>schizofreniei \u0219i tulbur\u0103rii bipolare de tip I<\/strong>. Este echivalent clinic cu formul\u0103rile de olanzapine de marc\u0103, cum ar fi <strong>Zyprexa<\/strong> \u0219i este utilizat la nivel mondial din anii 1990. Fiecare comprimat Onlee-10 con\u021bine 10 mg de olanzapine, doza zilnic\u0103 cea mai frecvent prescris\u0103 pentru adul\u021bii care \u00eencep terapia antipsihotic\u0103.<\/p>\n<p>Olanzapina este eficient\u0103 at\u00e2t pentru <strong>simptomele pozitive ale psihozei<\/strong> (halucina\u021bii, idei delirante, g\u00e2ndire dezorganizat\u0103) c\u00e2t \u0219i pentru <strong>simptomele afective<\/strong> ale tulbur\u0103rii bipolare (mania acut\u0103, episoade mixte \u0219i stabilizarea st\u0103rii de spirit pe termen lung). Se administreaz\u0103 de obicei o dat\u0103 pe zi, seara, \u0219i func\u021bioneaz\u0103 cel mai bine atunci c\u00e2nd este luat \u00een mod constant ca parte a unui plan de tratament general care include psihoterapie \u0219i sprijin social.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Onlee-10?<\/h2>\n<p>Onlee-10 este un medicament generic fabricat \u00een India, care con\u021bine <strong>olanzapin\u0103<\/strong>, un antipsihotic atipic din clasa tienobenzodiazepinelor. Olanzapina figureaz\u0103 pe Lista Medicamentelor Esen\u021biale a Organiza\u021biei Mondiale a S\u0103n\u0103t\u0103\u021bii din 2017 \u0219i r\u0103m\u00e2ne unul dintre cele mai prescrise antipsihotice de genera\u021bia a doua la nivel mondial.<\/p>\n<p>Onlee-10 este de obicei prescris pentru:<\/p>\n<ul>\n<li><strong>Schizofrenie<\/strong> \u2014 at\u00e2t episoade acute c\u00e2t \u0219i \u00eentre\u021binere pe termen lung<\/li>\n<li><strong>Episoade maniace sau mixte acute<\/strong> ale tulbur\u0103rii bipolare de tip I, ca monoterapie sau \u00een combina\u021bie cu litiu\/valproat<\/li>\n<li><strong>Terapie de \u00eentre\u021binere pentru tulburarea bipolar\u0103 de tip I<\/strong> pentru a preveni recidiva<\/li>\n<li><strong>Depresie rezistent\u0103 la tratament<\/strong> ca tratament adjunct (adesea combinat cu fluoxetin\u0103)<\/li>\n<li><strong>Agita\u021bie sever\u0103<\/strong> \u00een contextul psihozei sau maniei (utilizare \u00een spital)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Onlee-10?<\/h2>\n<p>Olanzapina apar\u021bine clasei de <strong>antipsihotice atipice<\/strong> \u0219i ac\u021bioneaz\u0103 asupra mai multor sisteme de neurotransmi\u021b\u0103tori din creier. Acest profil receptor mai larg este ceea ce o diferen\u021biaz\u0103 de antipsihoticele \u201ctipice\u201d mai vechi, cum ar fi haloperidolul.<\/p>\n<ul>\n<li><strong>Antagonismul receptorului de dopamin\u0103 D2<\/strong> \u00een calea mezolimbic\u0103 reduce simptomele pozitive ale psihozei, cum ar fi halucina\u021biile \u0219i ideile delirante<\/li>\n<li><strong>Antagonismul receptorului de serotonin\u0103 5-HT2A<\/strong> ajut\u0103 la ameliorarea simptomelor negative \u0219i reduce povara efectelor secundare extrapiramidale asociate cu medicamentele care blocheaz\u0103 doar dopamina<\/li>\n<li><strong>Blocarea histaminic\u0103 H1<\/strong> contribuie la efectul sedativ, care poate fi util pentru insomnie sau agita\u021bie acut\u0103, dar \u0219i la cre\u0219terea \u00een greutate<\/li>\n<li><strong>Blocarea muscarinic\u0103 M1<\/strong> produce efecte anticolinergice (gur\u0103 uscat\u0103, constipa\u021bie)<\/li>\n<li><strong>Blocarea adrenergic\u0103 alfa-1<\/strong> contribuie la hipotensiunea ortostatic\u0103, \u00een special \u00een timpul titr\u0103rii dozei<\/li>\n<\/ul>\n<p>Concentra\u021bia plasmatic\u0103 maxim\u0103 este atins\u0103 \u00een aproximativ <strong>5\u20138 ore<\/strong>, iar timpul de \u00eenjum\u0103t\u0103\u021bire este de <strong>21\u201354 de ore<\/strong> \u2014 suficient de lung pentru administrare o dat\u0103 pe zi. Nivelurile sanguine constante sunt de obicei atinse \u00een aproximativ o s\u0103pt\u0103m\u00e2n\u0103 de administrare consecvent\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Schizofrenie (acut\u0103 \u0219i de men\u021binere):<\/strong> olanzapina este considerat\u0103 unul dintre antipsihoticele de genera\u021bia a doua mai eficiente \u00een cazurile rezistente la tratament<\/li>\n<li><strong>Tulburare bipolar\u0103 I \u2014 manie acut\u0103 sau episoade mixte<\/strong> ca monoterapie sau cu un stabilizator de dispozi\u021bie<\/li>\n<li><strong>Men\u021binerea tulbur\u0103rii bipolare I<\/strong> pentru a reduce riscul de recidiv\u0103 \u00een manie sau depresie<\/li>\n<li><strong>Depresie cu tr\u0103s\u0103turi psihotice<\/strong> c\u00e2nd este asociat\u0103 cu un SSRI<\/li>\n<li><strong>Tulburare depresiv\u0103 major\u0103 rezistent\u0103 la tratament<\/strong> (de obicei combinat\u0103 cu fluoxetina sub forma Symbyax \/ OFC)<\/li>\n<li><strong>Managementul pe termen scurt al agita\u021biei severe<\/strong> \u00een medii psihiatrice pentru pacien\u021bi interna\u021bi<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Onlee-10 Dozare \u0219i administrare<\/h2>\n<p>Doza individual\u0103 variaz\u0103 \u00een func\u021bie de diagnostic, v\u00e2rst\u0103 \u0219i r\u0103spuns. Tratamentul \u00eencepe de obicei cu o <strong>doz\u0103 ini\u021bial\u0103 mai mic\u0103<\/strong> \u0219i este ajustat\u0103 cresc\u0103tor dup\u0103 necesit\u0103\u021bi.<\/p>\n<table>\n<thead>\n<tr>\n<th>Indica\u021bie \/ Pacient<\/th>\n<th>Doza ini\u021bial\u0103<\/th>\n<th>Interval efectiv obi\u0219nuit<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Schizofrenie (adul\u021bi)<\/strong><\/td>\n<td>5\u201310 mg o dat\u0103 pe zi<\/td>\n<td>10\u201320 mg pe zi<\/td>\n<\/tr>\n<tr>\n<td><strong>Manie acut\u0103 bipolar\u0103 (monoterapie)<\/strong><\/td>\n<td>10\u201315 mg o dat\u0103 pe zi<\/td>\n<td>10\u201320 mg pe zi<\/td>\n<\/tr>\n<tr>\n<td><strong>Manie acut\u0103 bipolar\u0103 (combina\u021bie)<\/strong><\/td>\n<td>10 mg o dat\u0103 pe zi<\/td>\n<td>5\u201320 mg cu litiu sau valproat<\/td>\n<\/tr>\n<tr>\n<td><strong>Men\u021binere bipolar\u0103<\/strong><\/td>\n<td>Continua\u021bi doza acut\u0103 eficient\u0103<\/td>\n<td>5\u201320 mg pe zi<\/td>\n<\/tr>\n<tr>\n<td><strong>Tratament adjunct \u00een depresie<\/strong><\/td>\n<td>5 mg seara<\/td>\n<td>5\u201315 mg cu fluoxetin\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>V\u00e2rstnici (65+) sau debilita\u021bi<\/strong><\/td>\n<td>2,5\u20135 mg pe zi<\/td>\n<td>Titra\u021bi cu precau\u021bie; nu dep\u0103\u0219i\u021bi 10 mg f\u0103r\u0103 supraveghere specializat\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Insuficien\u021b\u0103 hepatic\u0103<\/strong><\/td>\n<td>5 mg pe zi<\/td>\n<td>Titrare atent\u0103; monitoriza\u021bi testele hepatice (LFTs)<\/td>\n<\/tr>\n<tr>\n<td><strong>Doza zilnic\u0103 maxim\u0103<\/strong><\/td>\n<td>20 mg<\/td>\n<td>Dozele mai mari rareori ofer\u0103 beneficii suplimentare<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 class=\"wp-block-heading\">Cum s\u0103 lua\u021bi corect Onlee-10<\/h3>\n<ul>\n<li>Lua\u021bi Onlee-10 <strong>o dat\u0103 pe zi, la aceea\u0219i or\u0103 \u00een fiecare zi<\/strong> \u2014 majoritatea pacien\u021bilor o iau seara din cauza efectului sedativ<\/li>\n<li>Poate fi luat <strong>cu sau f\u0103r\u0103 m\u00e2ncare<\/strong> \u2014 alimenta\u021bia nu afecteaz\u0103 semnificativ absorb\u021bia<\/li>\n<li>\u00cenghi\u021bi\u021bi comprimatul \u00eentreg cu un pahar de ap\u0103<\/li>\n<li>Nu <strong>nu \u00eentrerupe\u021bi brusc Onlee-10<\/strong>, chiar dac\u0103 v\u0103 sim\u021bi\u021bi mai bine \u2014 \u00eentreruperea brusc\u0103 poate provoca recidiv\u0103 sau simptome de sevraj (insomnie, grea\u021b\u0103, transpira\u021bii). Reduce\u021bi progresiv doza sub supraveghere medical\u0103<\/li>\n<li>Dac\u0103 uita\u021bi o doz\u0103 \u0219i v\u0103 aminti\u021bi \u00een 12 ore, lua\u021bi-o. Dac\u0103 au trecut mai mult de 12 ore, omite\u021bi-o \u0219i relua\u021bi programul normal \u2014 nu lua\u021bi o doz\u0103 dubl\u0103<\/li>\n<li>Consecven\u021ba conteaz\u0103 \u2014 efectul antipsihotic se acumuleaz\u0103 \u00een 2\u20134 s\u0103pt\u0103m\u00e2ni de administrare constant\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare ale Onlee-10<\/h2>\n<p>Olanzapina este \u00een general bine tolerat\u0103 pentru eficacitatea psihiatric\u0103, dar are un profil de efecte secundare metabolice bine documentat care necesit\u0103 monitorizare continu\u0103.<\/p>\n<table>\n<thead>\n<tr>\n<th>Severitate<\/th>\n<th>Efect Secundar<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Foarte frecvente (\u22651 din 10)<\/strong><\/td>\n<td>Sedare\/somnolen\u021b\u0103, cre\u0219tere \u00een greutate (\u00een medie 3\u20137 kg), cre\u0219terea apetitului, ame\u021beli, hipotensiune ortostatic\u0103 u\u0219oar\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Frecvente (\u22651 din 100)<\/strong><\/td>\n<td>Gur\u0103 uscat\u0103, constipa\u021bie, cre\u0219tere a glicemiei la stomacul gol, cre\u0219tere a colesterolului \u0219i trigliceridelor, u\u0219oar\u0103 cre\u0219tere a transaminazelor, edem periferic, simptome extrapiramidale u\u0219oare (tremur, acatisie)<\/td>\n<\/tr>\n<tr>\n<td><strong>Pu\u021bin frecvente<\/strong><\/td>\n<td>Diabet zaharat de nou\u0103 apari\u021bie, hiperprolactinemie, disfunc\u021bie sexual\u0103, reten\u021bie urinar\u0103, discinezie tardiv\u0103 (la utilizare \u00eendelungat\u0103)<\/td>\n<\/tr>\n<tr>\n<td><strong>Rare, dar grave<\/strong><\/td>\n<td>Sindrom neuroleptic malign, cetoacidoz\u0103 diabetic\u0103, hiperglicemie sever\u0103, convulsii, agranulocitoz\u0103, hepatit\u0103, tromboembolism venos, accident vascular cerebral<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Cere\u021bi imediat aten\u021bie medical\u0103<\/strong> dac\u0103 experimenta\u021bi oricare dintre urm\u0103toarele:<\/p>\n<ul>\n<li>Febr\u0103 foarte ridicat\u0103, rigiditate muscular\u0103, confuzie (posibil sindrom malign neuroleptic)<\/li>\n<li>Mi\u0219c\u0103ri incontrollabile ale fe\u021bei, limbii sau membrelor<\/li>\n<li>Semne de hiperglicemie sever\u0103 \u2014 sete extrem\u0103, urinare frecvent\u0103, respira\u021bie cu miros fructat, respira\u021bie rapid\u0103<\/li>\n<li>Semne de cheag de s\u00e2nge \u2014 durere \u00een piept, dificultate de respira\u021bie, umflare sau durere \u00eentr-un picior<\/li>\n<li>Reac\u021bie alergic\u0103 sever\u0103 \u2014 umflare a fe\u021bei, g\u00e2tului sau limbii; dificultate de respira\u021bie<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Pacien\u021bi \u00een v\u00e2rst\u0103 cu psihoz\u0103 asociat\u0103 demen\u021bei:<\/strong> olanzapina este <strong>neaprobat<\/strong> contraindat\u0103 pentru aceast\u0103 indica\u021bie \u0219i are un avertisment \u00een cadru negru pentru risc crescut de mortalitate \u00een aceast\u0103 popula\u021bie specific\u0103<\/li>\n<li><strong>Monitorizare metabolic\u0103:<\/strong> se recomand\u0103 verific\u0103ri ini\u021biale \u0219i periodice ale greut\u0103\u021bii, circumferin\u021bei taliei, glicemiei la stomacul gol, HbA1c \u0219i profilului lipidic \u2014 ideal la \u00eenceput, dup\u0103 3 luni, apoi anual<\/li>\n<li><strong>Risc de diabet:<\/strong> olanzapina poate dezv\u0103lui sau agrava diabetul, chiar \u0219i f\u0103r\u0103 cre\u0219tere semnificativ\u0103 a greut\u0103\u021bii. Monitoriza\u021bi glicemia la stomacul gol la \u00eenceput \u0219i periodic<\/li>\n<li><strong>Risc cardiovascular:<\/strong> s-a observat o u\u0219oar\u0103 prelungire a intervalului QT; impactul metabolic este mai relevant clinic<\/li>\n<li><strong>Hipotenzie ortostatic\u0103:<\/strong> cea mai pronun\u021bat\u0103 \u00een timpul titr\u0103rii dozei \u2014 ridica\u021bi-v\u0103 \u00eencet din pozi\u021bia \u0219ez\u00e2nd\u0103 sau culcat\u0103<\/li>\n<li><strong>Pragul convulsiv:<\/strong> olanzapina scade u\u0219or pragul convulsiv; folosi\u021bi cu precau\u021bie la epilepsie sau la pacien\u021bi care iau medicamente proconvulsive<\/li>\n<li><strong>Afectare hepatic\u0103:<\/strong> \u00eencepe\u021bi cu doze mici (5 mg), monitoriza\u021bi testele hepatice (LFTs)<\/li>\n<li><strong>Sarcin\u0103 (Categoria C):<\/strong> expunerea \u00een trimestrul al treilea a fost asociat\u0103 cu semne extrapiramidale neonatale \u0219i simptome de sevraj \u2014 evalua\u021bi beneficiile \u00een raport cu riscurile \u00eempreun\u0103 cu specialistul dumneavoastr\u0103<\/li>\n<li><strong>Al\u0103ptarea:<\/strong> olanzapina trece \u00een laptele matern; discuta\u021bi echilibrul cu medicul prescriptor<\/li>\n<li><strong>Fumat:<\/strong> fumatul induce CYP1A2 \u0219i scade nivelurile de olanzapin\u0103 \u2014 renun\u021barea la fumat poate cre\u0219te nivelurile sanguine \u0219i poate necesita o revizuire a dozei<\/li>\n<li><strong>Alcool:<\/strong> intensific\u0103 sedarea; evita\u021bi sau limita\u021bi<\/li>\n<li><strong>Sensibilitate la c\u0103ldur\u0103:<\/strong> olanzapina afecteaz\u0103 reglarea temperaturii corporale \u2014 ave\u021bi grij\u0103 \u00een climat cald \u0219i \u00een timpul exerci\u021biilor fizice intense<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Hipersensibilitate cunoscut\u0103 la olanzapin\u0103 sau la orice excipient<\/li>\n<li>Glaucom cu unghi \u00eengust sever<\/li>\n<li>Depresie sever\u0103 a sistemului nervos central sau com\u0103 de orice origine<\/li>\n<li>Utilizarea concomitent\u0103 a medicamentelor cunoscute pentru a provoca prelungire semnificativ\u0103 a intervalului QT trebuie evaluat\u0103 caz cu caz<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table>\n<thead>\n<tr>\n<th>Medicament \/ Clas\u0103<\/th>\n<th>Interac\u021biune<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Fluvoxamin\u0103, ciprofloxacin\u0103<\/strong><\/td>\n<td>Inhibitori puternici ai CYP1A2 \u2014 pot dubla nivelurile plasmatice de olanzapin\u0103; reduce\u021bi doza de olanzapin\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Carbamazepin\u0103, fenitoin\u0103, rifampicin\u0103<\/strong><\/td>\n<td>Inductori ai CYP1A2 \u2014 reduc nivelurile de olanzapin\u0103; poate fi necesar\u0103 o doz\u0103 mai mare de olanzapin\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Fumat (tutun)<\/strong><\/td>\n<td>Induce CYP1A2; renun\u021barea la fumat poate cre\u0219te semnificativ nivelurile de olanzapin\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Benzodiazepine, opioide, alcool<\/strong><\/td>\n<td>Depresie aditiv\u0103 a SNC \u0219i respiratorie; utiliza\u021bi olanzapin\u0103 parenteral\u0103 + benzodiazepine IM cu mare precau\u021bie<\/td>\n<\/tr>\n<tr>\n<td><strong>Levodop\u0103, agonisti ai dopaminei<\/strong><\/td>\n<td>Efect antagonistic \u2014 olanzapina poate reduce eficacitatea medicamentelor pentru Parkinson<\/td>\n<\/tr>\n<tr>\n<td><strong>Antihipertensive<\/strong><\/td>\n<td>Efect hipotensiv aditiv \u2014 monitoriza\u021bi tensiunea arterial\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Anticolinergice<\/strong><\/td>\n<td>Efecte anticolinergice aditive (gur\u0103 uscat\u0103, constipa\u021bie, reten\u021bie urinar\u0103)<\/td>\n<\/tr>\n<tr>\n<td><strong>Alte medicamente care prelungesc intervalul QT<\/strong><\/td>\n<td>Risc combinat de aritmie \u2014 consulta\u021bi prescriptorul<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">\u00centreruperea Onlee-10<\/h2>\n<p>Olanzapina nu trebuie <strong>\u00eentrerupt\u0103 brusc<\/strong>. \u00centreruperea brusc\u0103 poate provoca:<\/p>\n<ul>\n<li>Insomnie de rebond, grea\u021b\u0103, transpira\u021bii, agita\u021bie<\/li>\n<li>\u201cPsihoz\u0103 de hipersensibilitate\u201d \u2014 rec\u0103dere rapid\u0103 a simptomelor psihotice sau maniacale<\/li>\n<li>Anxietate sever\u0103 sau disforie<\/li>\n<\/ul>\n<p>Practica standard este o <strong>reducere gradual\u0103 pe o perioad\u0103 de cel pu\u021bin 4 s\u0103pt\u0103m\u00e2ni<\/strong>, sub \u00eendrumarea unui psihiatru. Nu ajusta\u021bi doza f\u0103r\u0103 a discuta mai \u00eent\u00e2i cu clinicianul dumneavoastr\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>Se p\u0103streaz\u0103 la temperaturi sub 25 \u00b0C, \u00een loc uscat, departe de lumin\u0103 direct\u0103<\/li>\n<li>P\u0103stra\u021bi comprimatele \u00een blisterul original p\u00e2n\u0103 la utilizare<\/li>\n<li>P\u0103stra\u021bi la distan\u021b\u0103 de copii \u2014 ingestia accidental\u0103 de c\u0103tre un copil poate fi grav\u0103<\/li>\n<li>Nu se utilizeaz\u0103 dup\u0103 data de expirare tip\u0103rit\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Produse similare pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/synaptol\/\" rel=\"noopener\">Synaptol<\/a> \u2014 combina\u021bie utilizat\u0103 \u00een anumite afec\u021biuni neuropsihiatrice<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mens-health\/\" rel=\"noopener\">Medicamente pentru S\u0103n\u0103tatea Mintal\u0103<\/a> \u2014 explora\u021bi tratamente psihiatrice conexe<\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2t dureaz\u0103 p\u00e2n\u0103 \u00eencepe s\u0103 ac\u021bioneze Onlee-10?<\/h3>\n<p>Unele efecte \u2014 cum ar fi sedarea \u0219i reducerea agita\u021biei \u2014 apar \u00een primele zile. Efectul antipsychotic complet sau de stabilizare a dispozi\u021biei se dezvolt\u0103 de obicei \u00een <strong>2\u20136 s\u0103pt\u0103m\u00e2ni<\/strong> de utilizare zilnic\u0103 constant\u0103. Nu evalua\u021bi efectul s\u0103u doar \u00een prima s\u0103pt\u0103m\u00e2n\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Onlee-10 m\u0103 va face s\u0103 iau \u00een greutate?<\/h3>\n<p>Cre\u0219terea \u00een greutate este unul dintre cele mai frecvente efecte adverse, cu o medie de 3\u20137 kg \u00een primele 6 luni. Riscul este cel mai mare \u00een primele trei luni. Sfaturile dietetice timpurii, reducerea consumului de carbohidra\u021bi \u0219i exerci\u021biile fizice regulate pot limita semnificativ cre\u0219terea \u00een greutate. Prescriptorul dumneavoastr\u0103 ar trebui s\u0103 monitorizeze greutatea, talia, glicemia \u00een stare de post \u0219i lipidele la \u00eenceput \u0219i periodic.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 consum alcool \u00een timp ce iau Onlee-10?<\/h3>\n<p>Alcoolul intensific\u0103 efectele sedative \u0219i hipotensive ale olanzapinei \u0219i poate agrava starea psihiatric\u0103 pe care o trateaz\u0103. Este recomandat s\u0103 fie evitat; dac\u0103 totu\u0219i consuma\u021bi, men\u021bine\u021bi cantit\u0103\u021bi minime.<\/p>\n<h3 class=\"wp-block-heading\">Onlee-10 este dependentogen?<\/h3>\n<p>Olanzapina nu este dependentogen\u0103 \u00een sensul clasic - nu produce poft\u0103 sau stare de euforie. Cu toate acestea, \u00eentreruperea brusc\u0103 poate provoca simptome de sevraj \u0219i recidiv\u0103 psihiatric\u0103, motiv pentru care se recomand\u0103 reducerea treptat\u0103 a dozei.<\/p>\n<h3 class=\"wp-block-heading\">Onlee-10 poate fi utilizat \u00een timpul sarcinii?<\/h3>\n<p>Olanzapina este categoria C. Exist\u0103 situa\u021bii \u00een care beneficiul continu\u0103rii tratamentului dep\u0103\u0219e\u0219te riscul, dar aceasta trebuie s\u0103 fie o decizie luat\u0103 \u00eempreun\u0103 cu psihiatrul \u0219i obstetricianul. Expunerea \u00een trimestrul al treilea poate provoca simptome de sevraj la nou-n\u0103scut.<\/p>\n<h3 class=\"wp-block-heading\">Onlee-10 m\u0103 va face prea somnoros pentru a lucra?<\/h3>\n<p>Sedarea este de obicei mai puternic\u0103 \u00een primele s\u0103pt\u0103m\u00e2ni \u0219i adesea se atenueaz\u0103. Administrarea dozei seara poate minimiza somnolen\u021ba diurn\u0103. Nu conduce\u021bi sau opera\u021bi utilaje grele p\u00e2n\u0103 nu \u0219ti\u021bi cum v\u0103 afecteaz\u0103 Onlee-10.<\/p>\n<h3 class=\"wp-block-heading\">Onlee-10 poate fi divizat sau zdrobit?<\/h3>\n<p>Comprimatele conven\u021bionale de olanzapin\u0103 pot fi de obicei divizate dac\u0103 este necesar pentru titrarea dozei, dar zdrobirea nu este \u00een general recomandat\u0103. Dac\u0103 ave\u021bi dificult\u0103\u021bi \u00een \u00eenghi\u021birea comprimatelor, \u00eentreba\u021bi medicul despre formul\u0103rile orodispersibile de olanzapin\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Onlee-10 este acela\u0219i lucru cu Zyprexa?<\/h3>\n<p>Ambele con\u021bin 10 mg de olanzapin\u0103 \u0219i sunt bioechivalente. Onlee-10 este versiunea generic\u0103 indian\u0103; Zyprexa este marca original\u0103 Eli Lilly. Eficacitatea clinic\u0103 este identic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce ar trebui s\u0103 fac dac\u0103 uit s\u0103 iau o doz\u0103?<\/h3>\n<p>Dac\u0103 v\u0103 aminti\u021bi \u00een 12 ore, lua\u021bi doza ratat\u0103. Dac\u0103 au trecut mai mult de 12 ore, omite\u021bi-o \u0219i lua\u021bi urm\u0103toarea doz\u0103 la ora obi\u0219nuit\u0103. Nu lua\u021bi niciodat\u0103 dou\u0103 doze \u00eempreun\u0103 pentru a compensa o doz\u0103 ratat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">La ce intervale voi avea nevoie de controale \u00een timpul tratamentului cu Onlee-10?<\/h3>\n<p>Monitorizare tipic\u0103: examen fizic \u0219i analize de s\u00e2nge ini\u021biale (greutate, talie, glicemie la stomacul gol, HbA1c, panel lipidic, teste hepatice, hemogram\u0103), repetate dup\u0103 3 luni, apoi cel pu\u021bin anual. Psihiatrul dumneavoastr\u0103 va evalua progresul st\u0103rii mentale mai frecvent \u2014 de obicei la fiecare 2\u20134 s\u0103pt\u0103m\u00e2ni la \u00eenceput, \u0219i la fiecare 2\u20133 luni dup\u0103 stabilizare.<\/p>\n<p><!-- medsbase-faq-h3-converted --><\/p>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Onlee-10 la MedsBase este furnizat direct de la un produc\u0103tor certificat WHO-GMP \u00een ambalaj simplu \u0219i discret. Fiecare comand\u0103 este acoperit\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a> \u2014 perioad\u0103 de livrare de 20 de zile lucr\u0103toare sau retrimitem f\u0103r\u0103 costuri suplimentare \u2014 \u0219i se calific\u0103 pentru <a href=\"https:\/\/medsbase.com\/ro\/loyalty-points\/\">programul nostru de loialitate pentru clien\u021bi<\/a>. Livr\u0103rile sunt disponibile \u00een majoritatea destina\u021biilor la nivel mondial.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>S\u0103n\u0103tate general\u0103<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pepzol\/\">Pepzol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/olopat-eye-drop\/\">Olopat Pic\u0103turi Oculare<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/spectra\/\">Spectra<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/l-glutathione\/\">L-Glutathione<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mirzacan\/\">Mirzacan<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Onlee-10 (Olanzapin\u0103 10 mg) \u2014 tienobenzodiazepin\u0103 atipic\u0103 pentru schizofrenie \u0219i manie bipolar\u0103. Doz\u0103 fix\u0103 de 10 mg \u2014 doz\u0103 de \u00eentre\u021binere obi\u0219nuit\u0103.<\/p>","protected":false},"featured_media":58617,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3342,3906],"product_tag":[4527,4530],"class_list":{"0":"post-58616","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-general-health","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_tag-olanzapine","10":"product_tag-onlee-10","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/58616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=58616"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/58617"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=58616"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=58616"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=58616"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=58616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}